
Medikrebs Formulations Private Limited
About Medikrebs Formulations Private Limited
Data last updated:
Medikrebs Formulations Private Limited is a private limited company based in Dhar, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24304MP2016PTC041907. Its GSTIN is 23AAKCM6994J1ZU (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Harshit Agnihotri and Prakash Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dhar, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.12 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹1.84 Lakh (net margin -44.6%) and EBITDA of -₹1.18 Lakh (EBITDA margin -28.5%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medikrebs Formulations Private Limited's registered office is in Dhar, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 252, Sector – 1 Pithampur, Dhar, Madhya Pradesh, India – 454774
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medikrebs Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medikrebs Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medikrebs Formulations Private Limited, buy the company report.
Financials of Medikrebs Formulations Private Limited
FY 2025 filings availableMedikrebs Formulations Private Limited reported revenue of ₹4.12 Lakh (down 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 41% in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -28.5% | ||||
| Net Profit Margin | -44.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medikrebs Formulations Private Limited, buy the company report.
Board of directors of Medikrebs Formulations Private Limited
Medikrebs Formulations has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakash Sharma Also directs: Vedaherb Ventures LLP | Additional Director | 16 Oct 2020 | 6 Years 1 Months | Current |
| Harshit Agnihotri Also directs: Farmlinic Labs Private Limited, Hillock Homes Private Limited, Hshpt Drones Private Limited and 2 more | Director | 03 Dec 2025 | 0 Years 11 Months | Current |
| Charu Agnihotri | Additional Director | 03 Dec 2025 | 0 Years 11 Months | Current |
Peer comparison
Medikrebs Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genical Healthcare Private Limited | ₹4.17 Lakh (FY 2019) | 443.0% | Vadodara, Gujarat, India | |||
| Auropol Specialities Private Limited | ₹4.16 Lakh (FY 2024) | Kolkata, West Bengal, India | ||||
| Medikrebs Formulations Private Limitedthis company | ₹4.12 Lakh (FY 2025) | -₹1.84 Lakh | -44.6% | -41.0% | Dhar, Madhya Pradesh, India | |
| Surmount Formulations Private Limited | ₹4.09 Lakh (FY 2025) | 72.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Medikrebs Formulations Private Limited, buy the company report.
Auditor
Medikrebs Formulations Private Limited is audited by M P J & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M P J & Co | FY 2023 | 407340 |
Shareholding
The shareholding of Medikrebs Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medikrebs Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medikrebs Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medikrebs Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medikrebs Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAKCM6994J1ZU | Madhya Pradesh | Active | 21 Mar 2023 |
To see the full GST registrations and return filing status of Medikrebs Formulations Private Limited, buy the company report.
Recent activity
Medikrebs Formulations Private Limited has 9 board changes on record since 2016: 6 appointments and 3 cessations. The latest: Mangu Singh ceased to be Director on 10 Dec 2025.
Frequently asked questions
Medikrebs Formulations is an active private limited company based in Dhar, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 November 2016 (10+ years old) and is registered under CIN U24304MP2016PTC041907.
Medikrebs Formulations has 3 current directors:
- Prakash Sharma - Additional Director
- Harshit Agnihotri - Director
- Charu Agnihotri - Additional Director
The latest financial statements of Medikrebs Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Medikrebs Formulations is 23AAKCM6994J1ZU, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Medikrebs Formulations is U24304MP2016PTC041907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medikrebs Formulations was incorporated on 28 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Medikrebs Formulations by revenue are Genical Healthcare Private Limited, Auropol Specialities Private Limited, Surmount Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mangu Singh ceased to be Director on 10 Dec 2025. Charu Agnihotri was appointed as Additional Director on 03 Dec 2025. Harshit Agnihotri was appointed as Director on 03 Dec 2025. Medikrebs Formulations has 9 board changes on record in total.
The registered office of Medikrebs Formulations is at Plot No. 252, Sector – 1 Pithampur, Dhar, Madhya Pradesh, India – 454774.
Medikrebs Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Medikrebs Formulations is compliant as of 27 August 2026. The company is actively filing with the Registrar of Companies.

